Tenofovir DF + Lamivudine Tablets (300 mg + 100 mg)
Tenofovir DF + Lamivudine is a fixed-dose combination of two nucleos(t)ide reverse transcriptase inhibitors (NRTIs) that delivers a complementary antiviral backbone with overlapping activity against HIV-1 and hepatitis B. The single-tablet regimen simplifies dosing and supports treatment adherence.
Indicated for the treatment of HIV-1 infection in adults and adolescents in combination with at least one other antiretroviral agent, and widely used as a WHO-recommended NRTI backbone in resource-limited and high-burden settings.
Disclaimer
The content on this website is for general informational purposes only. While we strive for accuracy, RV Group makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.
Our Tenofovir DF + Lamivudine Tablets (300 mg + 100 mg) are also Available for
FAQ on Tenofovir DF + Lamivudine Tablets (300 mg + 100 mg)
Everything You Need to Know About RV Groups
RV Group operates through four integrated business verticals, each designed to create value across the pharmaceutical ecosystem.
Our Business
Quick Links
Contact
- hello@opv.vn
- +1 800 555 25 65